SEARCH

SEARCH BY CITATION

References

  • Åhlander M, Misane I, Schött PA, Ogren SO (1999). A behavioral analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK801 (dizolcipine) in the rat. Neuropsychopharmacol 21: 414426.
  • Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL (2000). Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99: 1723.
  • Bentley JC, Bourson A, Boess FG, Fone KCF, Marsden CA, Petit N et al. (1999). Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126: 15371542.
  • Callado LF, Hopwood SE, Hancock PJ, Stamford JA (2000). Effects of dizolcipine (MK801) on noradrenaline, serotonin and dopamine release and uptake. Neuroreport 17: 173176.
  • Callahan PM, Ilch CP, Rowe WB, Tehim A (2004). Characterization of the selective 5-HT6 receptor antagonist SB-271046. Soc Neurosci Meet 776: 19.
  • Daly DA, Moghaddam B (1993). Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci Lett 152: 6164.
  • Dawson LA, Li P, Nguyen HQ (2001). The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacol 25: 662668.
  • Dawson LA, Nguyen HQ, Li P (2000). In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130: 2326.
  • Diez-Ariza M, Redondo C, Garcia-Alloza M, Lasheras B, Del Rio J, Ramirez MJ (2003). Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats. Psychopharmacol 169: 3541.
  • Ferreri F, Agbokou C, Gauthier S (2006). Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy. J Psychi Neurosci 31: 369376.
  • Filliat P, Blanchet G (1995). Effects of TCP on spatial memory: comparison with MK-801. Pharmacol Biochem Behav 51: 429434.
  • Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N et al. (2004). The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacol 29: 93100.
  • Gage FH, Dunnett SB, Bjorklund A (1984). Spatial learning and motor deficits in aged rats. Neurobiol Aging 5: 4348.
  • Geerts H (2005). Indicators of neuroprotection with galantamine. Brain Res Bull 64: 519524.
  • Healy DJ, Meador-Woodruff JH (1999). Glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacol 21: 341351.
  • Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW et al. (2003a). Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 64: 12951308.
  • Hirst WD, Moss SF, Bromidge SM, Riley G, Stean TO, Rogers SC (2003b). Characterization of SB-399885, a potent and selective 5-HT6 receptor antagonist. Soc Neurosci Meet 576: 7.
  • King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004). 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism. Neuropharmacol 47: 195204.
  • Lieben CK, Blokland A, Sik A, Sung E, Van Nieuwenhuizen P, Schreiber R (2005). The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacol 30: 21692179.
  • Lindner MD, Hodges Jr DB, Hogan JB, Orie AF, Corsa JA, Barten DM et al. (2003). An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 307: 682691.
  • Loscher W, Annies R, Honack D (1993). Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioral effects in rats. Eur J Pharmacol 242: 263274.
  • Marcos B, Gil-Bea FJ, Hirst W, García-Alloza M, Ramírez MJ (2006). Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24: 12991306.
  • Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizo Bull 25: 233255.
  • Meneses A (2001). Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 118: 107110.
  • Meneses A, Manuel-Apolinar L, Castillo C, Castillo E (2007). Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: an autoradiographic study. Behav Brain Res 178: 5361.
  • Mitchell ES, Hoplight BJ, Lear SP, Neumaier JF (2006). BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism. Neuropharmacol 50: 412420.
  • Mitchell ES, Neumaier JF (2005). 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108: 320333.
  • Morris R (1984). Developments of a water maze procedure for studing spatial learning in the rat. J Neurosci Meth 11: 4760.
  • Perez-Garcia G, Meneses A (2005). Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 81: 673682.
  • Qing-Shan Y, Maarten EAR, Jobe PC, Dailey JW (1997). Dizolcipine (MK801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 765: 149158.
  • Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH et al. (2003). Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46: 12731276.
  • Rogers DC, Hagan JJ (2001). 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacol 158: 114119.
  • Roth BL, Roth BL, Hanizavareh SM, Blum AE (2004). Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacol 174: 1724.
  • Routledge C, Bromidge SM, Moss SF, Price G, Hirst W, Newman H et al. (2000). Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist. Br J Pharmacol 130: 16061612.
  • Russell MG, Dias R (2002). Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions. Curr Top Med Chem 2: 643654.
  • Schubert MH, Young KA, Hicks PB (2006). Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychi 60: 530533.
  • Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux on the hippocampus of the rat. Neuropsychopharmacol 26: 583594.
  • Sleight AJ, Boess FG, Bös M, Levet-Trafit B, Riemer C, Bourson A (1998). Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Br J Pharmacol 125: 556562.
  • Tollefson GD (1996). Cognitive function in schizophrenic patients. J Clin Psychi 11: 3139.
  • Wang H, Carlier PR, Ho WL, Wu DC, Lee NT, Li CPL et al. (1999). Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. Neuroreport 10: 789793.
  • Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992). MK801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J Neurochem 58: 15731575.
  • Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC (2001). A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacol 41: 210219.
  • Woolley ML, Marsden CA, Fone KC (2004). 5-ht6 receptors. Curr Drug Targets 3: 5979.